Ischemic Stroke

About the Disease
Stroke, Ischemic, also known as cerebral infarction, is related to sneddon syndrome and brain small vessel disease 1, and has symptoms including angina pectoris, back pain and chest pain. An important gene associated with Stroke, Ischemic is F5 (Coagulation Factor V), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Diseases of hemostasis. The drugs Heparin, bovine and Nadroparin have been mentioned in the context of this disorder. Affiliated tissues include Bone and Brain, and related phenotypes are stroke and homeostasis/metabolism

Common Targets
GLP1R | PTAFR | HLF | G5743 | CAPN2 | SENP3 | KMO | MicroRNA 4792 | KCNQ2 | F12 | MGP | CCDC159 | NLRP3 Inflammasome | MIR130B | PGAP1 | LOC105375175 | TCF7L2 | GRIN2B | NPR3 | CUBN | MIR4432 | RNLS | PM20D1 | KCNJ11 | MIRLET7I | RPS6KA4 | DNASE1 | TNFSF4 | CARD8 | ALOX15 | Acetyl-CoA Carboxylases (ACC) (nonspecified subtype) | Superoxide dismutase (SOD) (nonspecified subtype) | SLC12A2 | KLHL31 | MTHFR | Phosphodiesterase (nonspecified subtype) | CYP19A1 | CGAS | MIR149 | MMP1 | MIR4698 | GSTP1 | SCN5A | PRDX1 | HMOX1 | SCN2A | TBXAS1 | UGT1A10 | CD36 | CAT | MAS1L | PROKR2 | Glutamate Receptor Ionotropic AMPA Receptor | PROC | LINC01394 | CETP | ADK | SELE | PHACTR1 | G7422 | ADAMTS7 | LPL | MIR150 | TNFRSF11B | P2RY1 | CASP7 | RGS7 | Prolyl 4-hydroxylase | RTN4R | LRP6 | NAPA | Mitogen-activated protein kinase p38 (MAPK p38) (nonspecified subtype) | MIR320A | MTCL1 | PIK3CG | FFAR4 | Proteasome Complex | SLC9A1 | MIR323B | HRH3 | Na+/H+ Exchanger (NHE) (nonspecified subtype) | Corticotropin-Releasing Factor (CRF) Receptor (nonspecified subtype) | PLBD2 | XRCC1 | G5243 | CYP3A4 | VWF | CACNA1B | P2RX1 | G5599 | CTNNB1 | PUF60 | NTRK2 | HLA-DMA | SERPINA3 | G6647 | EDNRA | MPO | TRAF2 | 5-Hydroxytryptamine Receptor 3 (5-HT3 receptor) (nonspecified subtype) | G6714 | ATP6V0A4 | PDE4D | KCNAB2 | ADGRF1 | GPR35 | XIRP1 | XPC | GCH1 | ZPR1 | RPS6KA2 | m-Calpain | MIR200B | TLR7 | GHRL | Kainate Receptor (GluR) (nonspecified subtype) | Integrin alpha4beta1 (VLA-4) receptor | THSD4 | COMMD7 | SNORD78 | ZNF778 | NGFR | Calpain (nonspecified subtype) | IL10 | SKIC2 | LDLR | CALD1 | MIR933 | KNG1 | NOTCH3 | HP | RAC1 | HACD4 | TTR | SMG6 | GJA4 | PTPRD | Metabotropic glutamate (mGluR) receptor (nonspecified subtype) | FKBP4 | AVPR1A | TBPL1 | CAMSAP3 | Voltage-gated K(v) channel (nonspecified subtype) | XPNPEP1 | PTPRS | BDNF | ABL1 | GRIK1 | ABCA7 | PTGES | G114548 | ST3GAL3 | COX3 | CRBN | RYR1 | SLC18A2 | MC1R | F13A1 | HLA-DQB1 | TMCC3 | gamma-Secretase | APOA5 | CPS1 | CELF1 | IPCEF1 | NR1I3 | JCAD | G3576 | SRR | KCNA3 | TPP1 | BSG | TRAF3 | GRIN1 | GRM5 | GAS5 | L-type voltage-dependent calcium channel complex | CASS4 | NOS1AP | Cyclophilins (nonspecified subtype) | SFRP2 | GLIS3 | XPNPEP2 | EPHA1-AS1 | WNT2B | POR | AQP4 | ORAI1 | PTGER3 | Endothelin-Converting Enzymes (ECE) (nonspecified subtype) | IL12B | CYP2D6 | P4HA3 | ITGA2 | NUP210 | ANKS1A | SCNN1A | Tyrosine-Protein Kinases Src (nonspecified subtype) | SMO | G5594 | PTGIR | JAK2 | AHCY | NOS1 | P2RY2 | GNB3 | CEP170B | UBR3 | ALOX5AP | ADRA1A | CSK | Interleukin-1 (nonspecified subtype) | LGALS3 | MIR34A | ADTRP | PLA2G4A | MIR4268 | TRPV4 | Phosphodiesterase 1 (PDE1) (nonspecified subtype) | IKBKB | DRD4 | OPRK1 | MIR4277 | SLC17A3 | CYSLTR1 | SKIC3 | IL1RN | RPS6KA3 | CYP2C19 | THBS2 | FLG | G7015 | FGFR2 | GP1BA | ITGA2B | G7124 | DLGAP4 | C-X-C Chemokine Receptor CXCR1/CXCR2 (IL-8 Receptor) (nonspecified subtype) | VKORC1 | DGAT2 | MGLL | AGT | SLC35E1 | AVPR1B | MIR492 | LPAR1 | ADIPOQ | AMP-activated protein kinase (AMPK) | MIR155 | HDAC6 | Integrin alphavbeta3 (vitronectin) receptor | CD2AP | LOC105375733 | RTN4 | KCNQ3 | Calcium release-activated channel (CRAC) | Phospholipase A2 (nonspecified subtype) | PLCL1 | ICAM4 | G3620 | ACSL1 | PIP5K1B | HLA-DOA | Steroid 5-alpha-Reductase (nonspecified subtype) | EPHX2 | ALOX12 | AMBP | HDAC5 | MIR494 | Hedgehog Protein (nonspecified subtype) | NTN4 | G3725 | CA1 | T-Type Calcium Channel | COL4A1 | CALM1 | KCTD2 | PDE1C | MAPK11 | IMPA2 | ND1 | JMJD1C | HDAC7 | URAHP | HIF1A | APLNR | C5 | GSTO1 | MMAB | ROCK1 | Phosphodiesterase IV (PDE4) (nonspecified subtype) | G6774 | OPRM1 | MIR2117 | BAK1 | Heat shock protein 90 (nonspecified subtype) | MIR495 | HRH2 | CA12 | RAPGEF2 | IGFBP1 | UBE2Z | SLC22A3 | LPAL2 | CIRBP | MIR596 | SIGMAR1 | Alpha-2 Adrenergic receptors (nonspecified subtype) | MMP3 | CHRM1 | G6352 | Ribonucleoside-diphosphate reductase | ANXA5 | G3479 | IL-1 Receptor (nonspecified subtype) | ACE | ELANE | LOC102724428 | MIR497 | MIR122 | PINX1 | HTR4 | MED12L | CASR | CFDP1 | PLAA | MAPK12 | KCNK2 | NINJ2 | NOX4 | FLJ30679 | MIR143 | TF | ALDH2 | G842 | LCK | Alcohol Dehydrogenase (nonspecified subtype) | PIM3 | SPG21 | LIPA | MIR34B | LSM3 | PPARA | Integrin Receptor (nonspecified subtype) | Calcium channel (nonspecified subtype) | LTA | TRAF6 | F3 | NRF1 | GP5 | G5728 | CNR2 | IL1B | G1432 | MMP12 | ALPK1 | PDGFRL | TCF21 | CHFR | Lipoxygenase (nonspecified subtype) | IL4R | TGFB1 | CLU | Matrix Metalloproteinase (MMP) (nonspecified subtype) | LDHAL6A | PDE9A | CDK5 | PSMA6 | Glutamate Transporter (nonspecified subtype) | Calcium-Activated K(Ca) Potassium Channel (nonspecified subtype) | Phosphatidylinositol 3-kinase (PI3K) (nonspecified subtype) | DHX15 | PUM1 | RHPN1 | ADD1 | CXCR1 | ADAM17 | HHIPL1 | TNFSF11 | PTGIS | Myosin Class II (nonspecified subtype) | SLC6A9 | PSRC1 | FGA | PANX1 | KEAP1 | Protein Tyrosine Phosphatase (PTP) (nonspecified subtype) | MTHFD1L | SLC44A2 | G3569 | MIR605 | ESR2 | APOC3 | CYP2C8 | Opioid receptor (nonspecified subtype) | NDRG2 | Neurotrophic Factor (nonspecified subtype) | Chloride channel (nonspecified subtype) | Raf kinase (nonspecified subtype) | MVK | ZFHX3 | PRKAG2 | AVPR2 | F10 | CACNA1C | PCSK9 | Guanylate cyclase (nonspecified subtype) | HTR1A | ADORA1 | LOC650157 | TRPM8 | CELSR1 | VCAM1 | PECAM1 | LOC105374207 | HMGCR | PTPRJ | SLC6A2 | MAP2K1 | BCR | PGAM5-KEAP1-NRF2 Complex | FERMT2 | ROS1 | G4780 | G23411 | CD14 | Adenosine deaminase (nonspecified subtype) | DRD2 | MTRR | NPPA | G6772 | NEDD4 | NPPA-AS1 | GPX1 | KCNE1 | MASP2 | CDKN2B-AS1 | NR1I2 | CCL11 | MIR124-1 | CHRNA7 | MIR21 | EDNRB | ANAPC11 | PGR | ADA | Integrin alphaIIbbeta3 (fibrinogen gpIIb/IIIa) receptor | NF-kappaB (NFkB) | ABCA1 | CELSR2 | MIR34C | SETBP1 | HSD17B6 | ICAM1 | SELP | KCNC3 | NELFE | HLA-B | BCHE | G673 | MECOM | G7852 | CCNL2 | ZCWPW1 | CASP2 | PRKCH | MAP4K4 | SLC66A3 | Estrogen receptor (nonspecified subtype) | NPPB | P2RX4 | PSKH2 | TADA2B | CYP24A1 | ZNF208 | GCKR | GABA(A) receptor | SOD2 | MEF2C-AS1 | CNR1 | GALNT17 | CCR2 | DNAH11 | GSTO2 | MYH2 | NPY | DLG4 | P4HB | MAPK9 | CES1 | Na+/K+-ATPase (nonspecified subtype) | ND3 | PPARD | IGFBP3 | STAT5 (nonspecified subtype) | TRIM71 | ABCC9 | CD40 | PTK2B | MX1 | TRIM27 | VAPA | G581 | IL15RA | LOC100130987 | PTCH1 | SLC52A3 | TRIM46 | PDE4DIP | APAF1 | 15-Lipoxygenase (nonspecified subtype) | KCNA5 | TCN2 | FGB | OXT | CPB2 | SLC19A1 | MIR210 | PLAT | SNORD81 | Amyloid beta A4 precursor protein-binding family (APP-BP) (nonspecified subtype) | Reverse transcriptase (Telomerase) | G142 | AKT2 | K(ATP) Channel (nonspecified subtype) | G7099 | LHCGR | FERMT3 | PLG | HLA-DRB1 | RYR2 | P2RY12 | MIR3922 | Pyruvate dehydrogenase kinase (nonspecified subtype) | AKR1B1 | CYP2R1 | ADORA2A | LRRC26 | SYK | TSPO | FBXL7 | MIR3622A | G9734 | COL4A2 | SMARCA4 | MIR627 | MME | NTNG1 | FOXF2 | CASP8 | G3605 | Voltage-Gated Sodium Channel Complex | WRAP53 | WDR12 | F2 | BDNF-AS | STMN4 | MIR3679 | CXCL1 | sigma Receptor (nonspecified subtype) | Heme Oxygenase (HO) (nonspecified subtype) | Class III phosphatidylinositol 3-kinase (PI3-kinase) sub-complex | ADORA3 | CYP2J2 | Triacylglycerol Lipase (TG Lipase) (nonspecified subtype) | NTSR1 | OPRD1 | SERPINE1 | CBS | RASIP1 | ANKS1B | CHN1 | CHRM3 | TRPV1 | MIR3674 | PPP5C | CHUK | Prostanoid TP receptor (nonspecified subtype) | LRP1 | CHSY1 | SNORD80 | KCNE3 | TRPM4 | LIPC | FOLH1 | CAPN1 | GCLM | MIR499B | Integrin alpha2beta3 Receptor | XDH | PIK3C3 | TNFRSF11A | GSTT1 | OGA | LINC02210-CRHR1 | LOC105372028 | MALAT1 | TRPM2 | GSK3B | PTGS1 | PTPN1 | Glycogen synthase kinase 3 (GSK-3) (nonspecified subtype) | KCNE4 | ACHE | G9429 | HLA-A | Glycine receptor | CRYBA2 | EPOR | PPARG | NAA25 | SERPINF2 | NRXN2 | HDAC4 | F5 | CXCL2 | CYP3A5 | HNF1A | G3480 | IL5RA | Integrin alphaLbeta2 (LFA-1) receptor | PKM | GGT1 | ASB10 | Vascular endothelial growth factor receptor (VEGFR) (nonspecified subtype) | SST | PROKR1 | ABCC8 | MMP13 | CR1 | PAPPA | CRHR1 | PCK1 | BCAP29 | Caspase (nonspecified subtype) | ZC3HC1 | G2099 | KCNE2 | ST3GAL4 | PDE11A | MIR4669 | KIF21A | CHI3L1 | CHRM5 | FGFR1 | EFCAB12 | RNF126 | CLK1 | TXNRD1 | FGFR4 | GABRA5 | GRM1 | RAF1 | G3630 | MIPOL1 | KCNJ8 | L-Type calcium channel (nonspecified subtype) | KCNQ1 | VAMP8 | Sodium channel (nonspecified subtype) | LMOD1 | PATJ | Heat shock protein 70 (nonspecified subtype) | CISD1 | LIMASI | SHH | SLC2A1 | GMDS | PTGER1 | PTGES2 | GP6 | F2RL3 | KL | Adenosine receptor (nonspecified subtype) | CYP2C9 | FLT1 | TMEM97 | A1CF | FASN | SIK2 | G836 | CYSLTR2 | APOA1 | SLC24A4 | VCP | CYP4F2 | ITGB3 | HIF3A | Poly [ADP-ribose] polymerase (nonspecified subtype) | MAPK10 | KCNS3 | PON1 | ACYP2 | CTCFL | SLC2A9 | SGCZ | SRSF2 | ASIC1 | ECE1 | ERCC4 | PTPN22 | SNORD47 | KCNK17 | ADAMTS2 | AP-1 Transcription Factor Complex | CYP2B6 | LINC01094 | EGLN1 | NECTIN2 | SLC22A5 | HBEGF | GLB1L | PLAU | MMP8 | BAMBI | ASIC3 | ANXA1 | IL21 | Neurotensin receptor (nonspecified subtype) | IL1A | Hypoxia-Inducible Factor Prolyl Hydroxylase (nonspecified subtype) | Muscarinic Acetylcholine Receptor (mAChR) (nonspecified subtype) | MIR126 | TBXA2R | TIMP2 | C14orf119 | ARHGEF10 | Sterol Regulatory Element-Binding Protein (nonspecified subtype) | KCNH1 | G4318 | CDK5RAP3 | F11 | NOS3 | STK39 | Angiotensin receptor (AT) (nonspecified subtype) | LRRFIP1 | SEMA3A | VDAC2 | Large Conductance BK(Ca) Potassium Channel (Maxi K+ Channel) (nonspecified subtype) | CXCR2 | PEAR1 | TACR1 | MRAS | ATF6 | SMAD3 | G7157 | RAP1B | ITPKB | SIK1 | LIPE | LTC4S | PPM1A | SORL1 | ROCK2 | CYP4A11 | MIR4520-1 | RETN | HRH1 | Endothelin receptor (nonspecified subtype) | SLC6A4 | FGG | MTHFSD | LPA | SH2B3 | MAP2K2 | NLN | CXCL16 | F7 | RUVBL2 | Calcium/calmodulin-dependent protein kinase type II (CaMK-II) | CTSB | KLKB1 | SIRT7 | PDE5A | AGTR2 | RIPK3 | Gamma-glutamyl transferase (nonspecified subtype) | WT1 | APOB | APP | AGTR1 | ND5 | CASP1 | CASP6 | alpha-Amylase (nonspecified subtype) | ITCH | LOC105379030 | G3146 | IL2 | NMDA receptor | MIR146A | C3 | PANK1 | PARP2 | RGMA | PON2 | AGER | ABAT | PARG | MIA3 | SPSB3 | Glutamate Receptor Ionotropic (nonspecified subtype) | NT5E | Nitric oxide synthase (NOS) (nonspecified subtype) | GPR182 | KCNA2 | PGK1 | HNF4G | NQO1 | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3 (PDE3) (nonspecified subtype) | MMP2 | MYH7B | DNAH14 | CNNM2 | IRAG1 | JMY | G367 | NLGN1 | Na+/Ca2+ Exchanger (NCX) (nonspecified subtype) | TERC | G4233 | ABCC1 | MS4A2 | PDE1A | P4HA2 | PLPP3 | MIR6843 | KRR1 | CYP2C18 | MYO5B | CCL2 | CRP | CX3CR1 | SLC8A1 | CYP11B2 | SLC1A2 | Mitogen-activated protein kinase (JNK) (nonspecified subtype) | SVIL | HTR2A | RPS6KA5 | PTPN11 | MIR196A2 | PIK3CA | TLR4/MD-2 complex | ADGRA2 | VAV3 | PRNP | MIR130A | GSTM1 | TAOK1 | ADH1C | ITPR1 | LTA4H | FCER1G | TRPA1 | Potassium Channels (nonspecified subtype) | VDR | LY96 | GLA | ECE2 | Rho kinase (ROCK) (nonspecified subtype) | OR2B6 | LINC00494 | KCNB1 | RIPK1 | Epoxide Hydrolase (nonspecified subtype) | Voltage-Gated Calcium Channel alpha-2/delta (nonspecified subtype) | RPS6KA1 | NOS2 | TLR9 | GNAZ | TERF1 | UCP2 | LLGL2 | OXTR | ALOX5 | LIPG | MIR499A | CCR5 | IL21R | MIR300 | SLC22A11 | INPP5D | S1PR1 | PDGFRA | mu-Calpain (calpain 1) | RHOA | VHL | SETD7 | EGLN3 | APOE | SHMT1 | SLC6A3 | MAOB | NGF

Note: If you'd like to get a target analysis report for Ischemic Stroke, or if you are interested to learn how our AI-powered BDE-Chem can design therapeutic molecules to interact with the target(s) above against the disease of Ischemic Stroke at a cost 90% lower than traditional approaches, please feel free to contact us at BD@silexon.ai.

Other Diseases

Hyperphosphatasia With Intellectual Disability Syndrome 4 | Molybdenum Cofactor Deficiency | Melnick-Needles Syndrome | Hypoglycemia | Waardenburg Syndrome Type 2E | Chediak-Higashi Syndrome | Hyperprolactinemia | Dengue Hemorrhagic Fever | Hereditary Pyropoikilocytosis | Androgen Insensitivity | Asthma | Anorectal Fistula | Carcinoma, Squamous Cell | Triple A Syndrome | Pain | GNE Myopathy | Leukocyte Adhesion Deficiency Type 1 | Fragile X Syndrome | Antley-Bixler Syndrome | Rhabdomyosarcoma | Calcium Pyrophosphate Deposition Disease | Christianson Syndrome | Argininosuccinic Aciduria | Raynaud Phenomenon | Sweet Syndrome | Chronic Myeloid Leukemia | Nephritis, Interstitial | Lyme Disease | Myotonia | Coffin-Lowry Syndrome | Pneumonia, Mycoplasma | Usher Syndrome Type II | Charcot-Marie-Tooth Disease Type 4E | Lymphoma, Follicular | Epithelial-myoepithelial Carcinoma | Delayed Sleep Phase Syndrome | Spitzoid Melanoma | Microcephaly, Seizures, And Developmental Delay | Hypercholesterolemia, Familial | Hyperferritinemia-cataract Syndrome | Osteogenesis Imperfecta Type I | Long QT Syndrome Type 1 | Mucormycosis | Fahr Disease | Glycogen Storage Disease Type 9 | Persistent Fetal Circulation | Anemia | Amyotrophic Lateral Sclerosis, Juvenile | Adenosine Deaminase Deficiency | Glaucoma, Congenital | Sclerosteosis | Becker Muscular Dystrophy | Paroxysmal Nocturnal Hemoglobinuria | Thyroid Hormone Resistance | Pericarditis | Cherubism | Familial Cerebral Amyloid Angiopathy | Primary Hyperoxaluria | Infertility | Leukoencephalopathy, Progressive Multifocal | Shock, Cardiogenic | Sepiapterin Reductase Deficiency | Lymphedema | Neurodermatitis | Epidermolysis Bullosa Simplex, Generalized | Sclerosteosis 2 | Hypothalamic Obesity | Congenital Hereditary Endothelial Dystrophy Type II | Tylosis With Esophageal Cancer | Donnai-Barrow Syndrome | Renpenning Syndrome | Lateral Meningocele Syndrome | Primary Erythromelalgia | Glycogen Storage Disease Type 1 | Generalized Epilepsy And Paroxysmal Dyskinesia | Walker-Warburg Syndrome | Non-small Cell Lung Cancer | Cancer, Skin | Polycystic Liver | Gnathodiaphyseal Dysplasia | Hypotrichosis | Mast Cell Leukemia | Larsen Syndrome | Familial Isolated Hyperparathyroidism | Proctitis | CREST Syndrome | Pulmonary Capillary Hemangiomatosis | Benign Hereditary Chorea | Glanzmann Thrombasthenia | Hyperbilirubinemia | Emery-Dreifuss Muscular Dystrophy | Macrodactyly | Hereditary Sensory And Autonomic Neuropathy | Fraser Syndrome | Plasmacytoma | Urofacial Syndrome | X-linked Creatine Transporter Deficiency | Pernicious Anemia | Wolfram Syndrome | Partington Syndrome | Avian Influenza | Brachydactyly | Bruck Syndrome | Metabolic Syndrome | Congenital Disorders Of Glycosylation Type II | Iron Deficiency Anemia | Mucolipidosis Type III | Papilloma | GM2-gangliosidosis AB Variant | Chromosome 8q21.11 Deletion Syndrome | Eosinophilia | Bernard-Soulier Syndrome | Narcolepsy | Empyema | DOCK8 Immunodeficiency Syndrome | Aicardi-Goutieres Syndrome | Menkes Disease | Neurodegeneration With Brain Iron Accumulation | Congenital Nephrotic Syndrome | Shwachman-Bodian-Diamond Syndrome | Juvenile Myelomonocytic Leukemia | Asthma, Exercise-induced | Trichomegaly | Intellectual Disability, Autosomal Dominant 5 | T-cell Lymphoma, Subcutaneous Panniculitis-like | Erysipelas | Facioscapulohumeral Muscular Dystrophy | Lymphoma, Primary Cutaneous Anaplastic Large Cell | Nemaline Myopathy | Bronchiectasis | Charcot-Marie-Tooth Disease, Type 2C | VACTERL/VATER Association | Cardiofaciocutaneous Syndrome | Polycythemia Vera | Myopathy | Myositis, Focal | Influenza | Oculocutaneous Albinism Type 4 | Hypohidrotic Ectodermal Dysplasia, X-linked | Gaucher Disease | Spinocerebellar Ataxia | Diabetes Type 2 | Tinea | Rhabdomyosarcoma, Alveolar | Pulmonary Vein Stenosis | Thalassemia, Beta | Robinow Syndrome | Dysmorphophobia | Kidney Stones | Mixed Connective Tissue Disease | Parkinson Disease 6, Autosomal Recessive Early-onset | Paronychia | Porencephaly | Glomerulonephritis | Obesity | Spondylosis | Pemphigoid | Mycosis Fungoides | Acute Generalized Exanthematous Pustulosis | Apraxia | Thrombophlebitis | Tendinopathy | Histoplasmosis | Chondrodysplasia Punctata 1, X-linked Recessive | Intestinal Tuberculosis | Spermatocele | Hereditary Hemorrhagic Telangiectasia Type 2 | Pseudohermaphroditism | Lathosterolosis | L-2-Hydroxyglutaric Aciduria | Encephalopathy, Hepatic | Cardiomyopathy, Peripartum | Scleroderma | Porphyria, Variegate | Pachyonychia Congenita | Chronic Idiopathic Myelofibrosis | Spondyloarthritis | Lennox-Gastaut Syndrome | Thrombocythemia, Essential | Gastroenteritis | Neuropathy | Waardenburg Syndrome | Seizures | Pearson Syndrome | Chorea | Encephalopathy | Ocular Hypertension | Familial Hypertrophic Cardiomyopathy | Varicocele | Primrose Syndrome | Atrial Septal Defect | Lipid Storage Diseases | Mucolipidosis | Astrocytoma | Epidermolysis Bullosa Simplex, Dowling-Meara Type | Leishmaniasis, Cutaneous | Hypertriglyceridemia | Gardner Syndrome | Palsy, Cerebral | Genee-Wiedemann Syndrome | Adenosine Deaminase 2 Deficiency | Large Granular Lymphocytic Leukemia | Meningeal Melanocytoma | Hypersensitivity | Anti-NMDA Receptor Encephalitis | Lentigo | Vitelliform Macular Dystrophy | Oculodentodigital Dysplasia | Ligneous Conjunctivitis | Autosomal Recessive Bestrophinopathy | Multiple Congenital Anomalies-hypotonia-seizures Syndrome 2 | Lipid Metabolism Disorders | Keratoconjunctivitis | Martsolf Syndrome | Epidermolytic Hyperkeratosis | Usher Syndrome Type IIC | Cramp Fasciculation Syndrome | Peeling Skin Syndrome Type B | Muckle-Wells Syndrome | Split Hand-foot Malformation | Actinomycetoma | Currarino Syndrome | Pouchitis | Pathological Gambling | Spinocerebellar Ataxia Type 40 | Craniometaphyseal Dysplasia | Granular Corneal Dystrophy | Diabetes Insipidus | Spinal Muscular Atrophy Type 3 | Loeys-Dietz Syndrome Type 4 | Sleep Disorder | Congenital Dyserythropoietic Anemia | TARP Syndrome | Myosin Storage Myopathy | Tic Disorder | Mumps | Ichthyosis Bullosa Of Siemens | Angina Pectoris | Tangier Disease | Tuberculosis | Coloboma | Gastric Atrophy | Osteochondroma | Greenberg Dysplasia | Metatropic Dysplasia | Cardiomyopathy, Dilated, 1L | Mabry Syndrome | Krabbe Disease | Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3 | Sponastrime Dysplasia | Encephalitis | Early Infantile Epileptic Encephalopathy 4 | Kaposiform Hemangioendothelioma | Adenomatoid Tumor | Small Lymphocytic Lymphoma | Myocarditis | Hemangioendothelioma | Mitochondrial Cytopathy | Chondrosarcoma | Hypolipoproteinemia | Tardive Dyskinesia | Nephrotic Syndrome Type 1 | Arts Syndrome | Scabies | Von Hippel-Lindau Disease | Dysthymia | Enterocolitis, Necrotizing | Cardiomyopathy, Restrictive | Eccrine Porocarcinoma | Hemorrhagic Disorders | Orotic Aciduria | Reflex Epilepsy | Ophthalmoplegia | Amyotrophic Lateral Sclerosis | Beta-Propeller Protein-associated Neurodegeneration | Hereditary Multiple Exostoses | Dysfibrinogenemia | Isovaleric Acidemia | Asperger Syndrome | Iron Overload | Mitochondrial DNA Depletion Syndrome, Hepatocerebral Form | Meleda Disease | Dystonia Musculorum Deformans | Anorectal Malformations | Alexander Disease | Poirier-Bienvenu Neurodevelopmental Syndrome | Autonomic Neuropathy | Cystitis | Peyronie's Disease | Binge Eating Disorder | Schnitzler Syndrome | Glutathione Synthetase Deficiency | Rhinitis | Neuroblastoma | Rash | Pulmonary Stenosis | Parkinsonism | Ameloblastic Carcinoma | Melanoma, Uveal | Insulin Resistance | Trachoma | Leukodystrophies | Hereditary Sensory Neuropathy Type 1 | Myoclonus | Hypoalbuminemia | Chudley-McCullough Syndrome | Sensory Neuropathy | Hyperbilirubinemia, Neonatal | Alazami Syndrome | Hypophosphatasia | Keratoconus | Zellweger Syndrome | Toxic Epidermal Necrolysis | Angiosarcoma Of The Breast | Metachondromatosis | Sandhoff Disease | Klinefelter Syndrome | Focal Segmental Glomerulosclerosis | Cholelithiasis | Fetal And Neonatal Alloimmune Thrombocytopenia | Hydronephrosis | Benign Familial Pemphigus | Myositis | Nephrosclerosis | Pierpont Syndrome | Hermansky-Pudlak Syndrome | Hyperlipidemia Type V | Dwarfism | Cystitis, Interstitial | Osteosclerosis | Pitt-Hopkins Syndrome | Zollinger-Ellison Syndrome | Tenosynovial Giant Cell Tumor | Cystinosis | Familial Hemiplegic Migraine | Glutaric Aciduria Type 3 | Cole-Carpenter Syndrome | Neurodevelopmental Disorder With Central Hypotonia And Dysmorphic Facies | Acne | Hyperekplexia | Cerebellofaciodental Syndrome | Angiomyolipoma | Congenital Muscular Dystrophy | Antithrombin III Deficiency | Fibromuscular Dysplasia | Corneal Dystrophy | Kearns-Sayre Syndrome | Acute Lymphocytic Leukemia | Glycogen Storage Disease Type 6 | Urticaria | Poretti-Boltshauser Syndrome | Osteogenesis Imperfecta Type III | Meniere's Disease | Infertility, Male | Pyruvate Dehydrogenase Deficiency | Primary Biliary Cholangitis | Primary Sclerosing Cholangitis | Antiphospholipid Syndrome | Intestinal Hypomagnesemia 1 | 5-oxoprolinase Deficiency | Heterotaxy | Microcephalic Osteodysplastic Primordial Dwarfism, Type II | Cockayne Syndrome | Congenital Dyserythropoietic Anemia Type 1 | Retinal Dystrophy | Olmsted Syndrome | Angioedema, Acquired | Diabetic Encephalopathy | Adenoid Cystic Carcinoma | Odonto-onycho-dermal Dysplasia | Craniolenticulosutural Dysplasia | Hyper IgE Syndrome | Pyelonephritis | Sulfite Oxidase Deficiency | Phenylketonuria II | Nasodigitoacoustic Syndrome | Frontometaphyseal Dysplasia | Congenital Hemolytic Anemia | Uterine Leiomyoma | Chitayat Syndrome | Charcot-Marie-Tooth Disease, Type 2A | Steel Syndrome | Neurodegeneration Due To Cerebral Folate Transport Deficiency | Behcet's Disease | Malignant Fibrous Histiocytoma | Congenital Myopathy | Charcot-Marie-Tooth Disease Type 2D | Spondylometaphyseal Dysplasia | Polyomavirus Nephropathy | Scoliosis | Pontocerebellar Hypoplasia Type 2 | Hemolytic Uremic Syndrome | Lactose Intolerance | Stargardt Disease | Microphthalmia | Cheilitis | Potocki-Shaffer Syndrome | Klippel-Feil Syndrome | Megacystis-microcolon-intestinal Hypoperistalsis Syndrome | 3-M Syndrome